Our Science – Turkbey Website
Ismail Baris Turkbey, M.D.
Selected Publications |
 |
| 1)
Liu W, Turkbey B, Sénégas J, Remmele S, Xu S, Kruecker J, Bernardo M, Wood BJ, Pinto PA, Choyke PL. Accelerated T2 mapping for characterization of prostate cancer. Magn Reson Med. 65: 1400-6, 2011. [Journal] |
|
| 2)
Yan P, Xu S, Turkbey B, Kruecker J. Adaptively learning local shape statistics for prostate segmentation in ultrasound. IEEE Trans Biomed Eng. 58: 633-41, 2011. [Journal] |
|
| 3)
Rastinehad AR, Baccala AA, Chung PH, Proano JM, Kruecker J, Xu S, Locklin JK, Turkbey B, Shih J, Bratslavsky G, Linehan WM, Glossop ND, Yan P, Kadoury S, Choyke PL, Wood BJ, Pinto PA. D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J. Urol. 185: 815-20, 2011. [Journal] |
|
| 4)
Kojima C, Turkbey B, Ogawa M, Bernardo M, Regino CA, Bryant LH, Choyke PL, Kono K, Kobayashi H. Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics. Nanomedicine : nanotechnology, biology, and medicine. 2011. [Journal] |
|
| 5)
Turkbey B, Aras O, Karabulut N, Turgut AT, Akpinar E, Alibek S, Pang Y, Erturk SM, El Khouli RH, Bluemke DA, Choyke PL. Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging. Diagnostic and interventional radiology (Ankara, Turkey). 2011. [Journal] |
|
| 6)
Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Bernardo M, Merino MJ, Wood BJ, Choyke PL, Pinto PA. Documenting the location of prostate biopsies with image fusion. BJU Int. 107: 53-7, 2011. [Journal] |
|
| 7)
Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Shah V, Bernardo M, Baccala A, Rastinehad A, Benjamin C, Merino MJ, Wood BJ, Choyke PL, Pinto PA. Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI. Cancer Imaging. 11: 31-6, 2011. [Journal] |
|
| 8)
Kelly RJ, Rajan A, Force J, Lopez-Chavez A, Keen C, Cao L, Yu Y, Choyke P, Turkbey B, Raffeld M, Xi L, Steinberg SM, Wright JJ, Kummar S, Gutierrez M, Giaccone G. Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib. Clin. Cancer Res. 17: 1190-9, 2011. [Journal] |
|
| 9)
Turkbey B, Shah VP, Pang Y, Bernardo M, Xu S, Kruecker J, Locklin J, Baccala AA, Rastinehad AR, Merino MJ, Shih JH, Wood BJ, Pinto PA, Choyke PL. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?. Radiology. 258: 488-95, 2011. [Journal] |
|
| 10)
Pinto PA, Chung PH, Rastinehad AR, Baccala AA, Kruecker J, Benjamin CJ, Xu S, Yan P, Kadoury S, Chua C, Locklin JK, Turkbey B, Shih JH, Gates SP, Buckner C, Bratslavsky G, Linehan WM, Glossop ND, Choyke PL, Wood BJ. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J. Urol. 186: 1281-5, 2011. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 9/26/2011.
